Flu Vaccine
Mount Sinai School of Medicine of New York University demands $15 million from Medimmune, for royalties on a patent license Medimmune allegedly used to develop an H1N1 vaccine, in New York County Court.
Mount Sinai School of Medicine of New York University demands $15 million from Medimmune, for royalties on a patent license Medimmune allegedly used to develop an H1N1 vaccine, in New York County Court.